CORT

MKT CAP:$8B

Corcept Therapeutics Incorporated

Market Cap

$8B

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$73.33+$35.13 (+91.96%)

Jun 8, 2026

52W High $90.3252W Low $32.15

Company Details

Corcept Therapeutics Incorporated, a biopharmaceutical company, engages in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States. The company offers ...

CEO

—

IPO Date

Apr 14, 2004

Website

www.corcept.com

Key Metrics TTM

Revenue

$769M

+12.2% YoY

Net Income

$48M

EPS (Diluted)

Free Cash Flow

$120M

Revenue / Share

$7.36

Gross Margin

98.3%

Operating Margin

-1.1%

Net Margin

6.2%

FCF Margin

15.6%

P/S

9.8x

P/E

157.9x

Earnings Reports

Q2 2026

Jul 30, 2026

PENDING

Q1 2026

Apr 30, 2026

$165M+4.9%

FY 2025

Feb 24, 2026

$761M+12.8%

Q4 2025

Feb 24, 2026

$202M+11.1%

Q3 2025

Nov 4, 2025

$208M+13.7%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee